The United States hormone replacement therapy market is projected to record a CAGR of 7.62% during the forecast period, 2021-2026. The growing hormonal imbalance disorders and the rising geriatric population with such disorders are estimated to drive market growth.

UNITED STATES HORMONE REPLACEMENT THERAPY MARKET FORECAST 2021-2026

United States Hormone Replacement Therapy Market by Therapy Type (Estrogen Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Progestogen Hormone Replacement Therapy) Market by Indication (Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism, Other Indications) Market by Route of Administration (Oral, Parenteral, Transdermal, Other Route of Administrations)

Request free sample

The United States hormone replacement therapy market is projected to record a CAGR of 7.62% during the forecast period, 2021-2026. The growing hormonal imbalance disorders and the rising geriatric population with such disorders are estimated to drive market growth.united-states-hormone-replacement-therapy-market

To learn more about this report, request a free sample copy

In the United States, almost 1.3 million women between the ages of 51 and 52 go through menopause every year, according to the National Menopause Foundation. Around 5% of women aged between 40 and 45 go through early menopause. Whereas 1% of women before the age of 40 experience premature menopause, which is attributed to permanent ovarian failure associated with sex chromosome abnormalities. Further, as per the University of Wisconsin Hospitals and Clinics Authority, hypogonadism increases with age. It affects almost 19% of men in their 60s. In several cases, it remains underdiagnosed. Thus, the growing awareness about such diseases and disorders is expected to increase the market growth. Moreover, many key players are developing products with different formulations to increase patient acceptability and compliance.

ANI Pharmaceuticals Inc is an integrated specialty pharmaceutical company that develops, manufactures, and markets generic and branded prescription pharmaceuticals. Its areas of product development include hormones and steroids, complex formulations, oncolytic, and narcotics. The product portfolio includes Testosterone gel, ARIMIDEX, CASODEX, etc.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • COUNTRY SNAPSHOT
      • COUNTRY ANALYSIS
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
    3. KEY ANALYTICS
      • IMPACT OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRY
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    4. MARKET BY THERAPY TYPE
      • ESTROGEN HORMONE REPLACEMENT THERAPY
      • THYROID HORMONE REPLACEMENT THERAPY
      • TESTOSTERONE HORMONE REPLACEMENT THERAPY
      • HUMAN GROWTH HORMONE REPLACEMENT THERAPY
      • PROGESTOGEN HORMONE REPLACEMENT THERAPY
    5. MARKET BY INDICATION
      • MENOPAUSE
      • MALE HYPOGONADISM
      • GROWTH HORMONE DEFICIENCY
      • HYPOTHYROIDISM
      • OTHER INDICATIONS
    6. MARKET BY ROUTE OF ADMINISTRATION
      • ORAL
      • PARENTERAL
      • TRANSDERMAL
      • OTHER ROUTE OF ADMINISTRATIONS
    7. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
        • BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
      • COMPANY PROFILES
        • ABBOTT LABORATORIES
        • ANI PHARMACEUTICALS
        • ELI LILLY & COMPANY
        • NOVEN PHARMACEUTICALS INC
        • PFIZER INC
        • VIATRIS INC (MYLAN NV)

    LIST OF TABLES  

    TABLE 1: MARKET SNAPSHOT – HORMONE REPLACEMENT THERAPY

    TABLE 2: MARKET SNAPSHOT – HORMONE REPLACEMENT THERAPY

    TABLE 3: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 4: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 5: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 6: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 7: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 8: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 9: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 10: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2026 (IN $ MILLION)

    TABLE 11: LEADING PLAYERS OPERATING IN UNITED STATES HORMONE REPLACEMENT THERAPY MARKET

    TABLE 12: LIST OF MERGERS & ACQUISITIONS

    TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 14: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS

    TABLE 15: LIST OF BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS

    LIST OF FIGURES 

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, IN 2020

    FIGURE 6: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2026 (IN $ MILLION)

    FIGURE 7: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2026 (IN $ MILLION)

    FIGURE 8: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY, 2021-2026 (IN $ MILLION)

    FIGURE 9: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY, 2021-2026 (IN $ MILLION)

    FIGURE 10: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY, 2021-2026 (IN $ MILLION)

    FIGURE 11: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, IN 2020

    FIGURE 12: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2026 (IN $ MILLION)

    FIGURE 13: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2026 (IN $ MILLION)

    FIGURE 14: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2026 (IN $ MILLION)

    FIGURE 15: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2026 (IN $ MILLION)

    FIGURE 16: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY OTHER INDICATIONS, 2021-2026 (IN $ MILLION)

    FIGURE 17: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, IN 2020

    FIGURE 18: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2026 (IN $ MILLION)

    FIGURE 19: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2026 (IN $ MILLION)

    FIGURE 20: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2026 (IN $ MILLION)

    FIGURE 21: UNITED STATES HORMONE REPLACEMENT THERAPY MARKET, BY OTHER ROUTE OF ADMINISTRATIONS, 2021-2026 (IN $ MILLION)

    1. MARKET BY THERAPY TYPE
      • ESTROGEN HORMONE REPLACEMENT THERAPY
      • THYROID HORMONE REPLACEMENT THERAPY
      • TESTOSTERONE HORMONE REPLACEMENT THERAPY
      • HUMAN GROWTH HORMONE REPLACEMENT THERAPY
      • PROGESTOGEN HORMONE REPLACEMENT THERAPY
    2. MARKET BY INDICATION
      • MENOPAUSE
      • MALE HYPOGONADISM
      • GROWTH HORMONE DEFICIENCY
      • HYPOTHYROIDISM
      • OTHER INDICATIONS
    3. MARKET BY ROUTE OF ADMINISTRATION
      • ORAL
      • PARENTERAL
      • TRANSDERMAL
      • OTHER ROUTE OF ADMINISTRATIONS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type